Use The Relay Innovation Engine (RIE) for pre-clinical development strategy. The Relay Innovation Engine can support global Pharmaceutical companies and emerging biotechnology companies in their efforts to plan an effective pre-clinical development program for any asset in development. Develop a strong pre-clinical pipeline by:
Identifying new licensing opportunities:
- Unearth new pre-clinical assets that have high probability of success.
- Discover and objectively evaluate pre-clinical assets in your target category, including assets outside of the US.
Tracking pre-clinical asset performance over time:
- Create a custom dashboard to watch performance trends of target pre-clinical assets over time.
- See historic trend analysis for target pre-clinical assets.
Avoiding transactions with limited potential:
Monitor performance over time and avoid costly missteps.